Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.co.in
Google Alert - evommune
Get the latest updates from Google Alert - evommune directly as they happen.
Follow now 112 followers
Latest posts
Last updated about 19 hours ago
Evommune Initiates Phase 2b Trial of its Oral MRGPRX2 Antagonist, EVO756, in Adults with ...
about 20 hours ago
Evommune, Inc. is a clinical-stage biotechnology company discovering and developing innovative therapies...
Misinformation, Disinformation Threaten Clinician-Patient Relationship and Quality of Care
1 day ago
Evommune Launches Phase 2b Trial of Oral MRGPRX2 Antagonist, EVO756, In Adults...
Evommune Launches Phase 2b Trial of Oral MRGPRX2 Antagonist, EVO756, In Adults With ...
1 day ago
Evommune, Inc announced enrollment of the first participant in the company's phase...
Evommune Initiates Phase 2b Trial of its Oral MRGPRX2 Antagonist, EVO756, in Adults with ...
1 day ago
27, 2025 /PRNewswire/ -- Evommune, Inc., a clinical stage biotechnology company discovering...
Portfolio - Amplitude Ventures
21 days ago
Evommune. Evommune is creating game-changing science to treat immune-mediated inflammatory diseases by...
Inflammatory Disease - Therapy Areas - M2 Pharma.
about 1 month ago
Evommune initiates EVO756 Phase 2b trial in adults with chronic spontaneous urticaria...
脑瘤靶向疗法研发商GT Medical Technologies完成1600万美元D轮股权融资 - 动脉网
about 1 month ago
生物新药研发商Evommune宣布获得1.15亿美元C轮融资，以加快推进治疗慢性炎症性疾病的临床阶段管道. 潜力项目生物医药赛道过亿人民币. 2024-10-31 23:52 ...
Small molecule therapy(Evommune/Accutar Biotechnology)-靶点_适应症: 炎性疾病-临床
2 months ago
Small molecule therapy(Evommune/Accutar Biotechnology)是由Evommune Inc和冰洲石生物科技研发的一种小分子药物，目前该药物最高研发阶段为临床前， ...
Brian S. Kim on X: "Thank you to Evommune for sponsoring our Allen Discovery Center-Cell ...
2 months ago
Thank you to Evommune for sponsoring our Allen Discovery Center-Cell Symposia. Early...
Evommune | B Capital Job Board
2 months ago
Evommune is different. We strive to develop accessible innovations that are meant...
Evommune Scientist Medicinal Chemistry Job in Palo Alto, CA - ZipRecruiter
2 months ago
Evommune, Inc. is a private clinical-stage biotechnology company dedicated to revolutionizing the...
Venture Round - Evommune - 2025-01-07 - Crunchbase Funding Round Profile
3 months ago
Evommune raised $81799952 on 2025-01-07 in Venture Round.